Nadiya Teplyuk

Nadiya Teplyuk is an accomplished scientist with extensive experience in the biotechnology and pharmaceutical sectors, currently serving as a Senior Scientist at Benitec Biopharma Inc. since August 2025. Previously, Nadiya held the position of Principal Scientist at Sarepta Therapeutics from September 2018 to July 2025, focusing on the development and validation of analytical assays for AAV-based gene therapy products targeting muscular and neurological rare diseases. Nadiya has also worked as a Study Director at Toxikon Corporation, managing bioanalytical assays in both GLP and non-GLP environments, and as a Research Fellow at prestigious institutions including Harvard Medical School and MGH, contributing to pre-clinical research in brain cancer therapies. Nadiya's academic credentials include a Ph.D. in Molecular Biology from the Institute of Molecular Biology and Genetics in Ukraine, along with a Master's degree in Biochemistry and Molecular Biology and a Bachelor's degree in Biology from Taras Shevchenko National University of Kyiv.